Clinton Transition Team Includes Tanden, Underscoring Rx Pricing Focus
Center for American Progress President Neera Tanden has actively advocated Clinton’s position on prescription drug price controls over the past year.
You may also be interested in...
The Presidential Transition Teams: A Reunion of “Pfizer Pfriends”?
When Hillary Clinton’s transition team was announced last week, much of the coverage focused (appropriately) on the health care experience of one co-chair, Neera Tanden. But another co-chair, former Michigan Governor Jennifer Granholm, also has an interesting history with the largest US pharma company – and, indirectly, with a member of Donald Trump’s transition team.
Clinton Vs. Trump: Three Scenarios For Biopharma
The presidential campaign is about to begin in earnest, and for biopharma companies, the biggest question is what the outcome will mean for the pricing climate in the US. It isn’t an easy question to answer.
Drug Price Control Proposals Pared Down In Democrats’ Draft Platform
Draft includes only a selection of price control policies that have been offered by presumptive nominee Hillary Clinton and candidate Sen. Bernie Sanders on the campaign trail.